58124-18-8 Usage
Uses
Used in Health and Nutrition Industry:
2-Hydroxynaringenin is used as a dietary supplement for its potential health benefits, including anti-inflammatory and anti-cancer properties. It is believed to help regulate hormone levels in the body and may contribute to improved cardiovascular health.
Used in Pharmaceutical Industry:
2-Hydroxynaringenin is used as a potential therapeutic agent for various health conditions due to its anti-inflammatory and anti-cancer properties. It may be incorporated into pharmaceutical formulations to target specific health issues.
Used in Functional Foods and Beverages:
2-Hydroxynaringenin is used as an ingredient in functional foods and beverages to provide consumers with the potential health benefits associated with this natural compound, such as improved bone health and reduced risk of osteoporosis.
Used in Cosmetics and Personal Care Industry:
2-Hydroxynaringenin may be used as an active ingredient in cosmetics and personal care products for its potential anti-inflammatory and antioxidant properties, which could contribute to skin health and protection against environmental stressors.
Check Digit Verification of cas no
The CAS Registry Mumber 58124-18-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,8,1,2 and 4 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 58124-18:
(7*5)+(6*8)+(5*1)+(4*2)+(3*4)+(2*1)+(1*8)=118
118 % 10 = 8
So 58124-18-8 is a valid CAS Registry Number.
58124-18-8Relevant academic research and scientific papers
Urgineaglyceride A: A new monoacylglycerol from the Egyptian Drimia maritima bulbs
Mohamed, Gamal A.,Ibrahim, Sabrin R. M.,Shaala, Lamiaa A.,Alshali, Khalid Z.,Youssef, Diaa T. A.
, p. 1583 - 1590 (2015/11/04)
One new compound, (2S)-1-O-(Z)-tetracos-6-enoate glycerol (1) named urgineaglyceride A, along with six known compounds, 3,5,7,3′,5′-pentahydroxydihydroflavonol (2), stigmasterol (3), (25S)-5β-furostane-3β-22α-26-triol (4), scillaridin A (5), (2S)-(+)-2-hydroxynaringenin-4′-O-β-d-glucopyranoside (6) and quercetin-3′-O-β-d-glucopyranoside (7), were isolated from the EtOAc fraction of Drimia maritima (L.) Stearn bulbs. Their structures were secured based on their IR, UV, 1D and 2D NMR data, in addition to HR-MS data and comparison with the literature data. The isolated compounds were evaluated for their in vitro growth inhibitory activity against A549 non-small cell lung cancer (NSCLC), U373 glioblastoma (GBM) and PC-3 prostate cancer cell lines. Compounds 2 and 3 displayed variable activities against the tested cancer cell lines. Compound 2 was a selective inhibitor of the NSCLC cell line with an IC50 of 2.3 μM, whereas 3 was selective against GBM with IC50 of 0.5 μM and against PC-3 with 2.0 M.
